Mayr, M., Schulte, N., Belle, S., Hofheinz, R., & Ebert, M. (2012). Phase I study of imatinib, cisplatin and 5-fluoruracil or capecitabine in advanced esophageal and gastric adenocarcinoma. BMC cancer, 12, .
Chicago Style (17th ed.) CitationMayr, Martina, Nadine Schulte, Sebastian Belle, Ralf-Dieter Hofheinz, and Matthias Ebert. "Phase I Study of Imatinib, Cisplatin and 5-fluoruracil or Capecitabine in Advanced Esophageal and Gastric Adenocarcinoma." BMC Cancer 12 (2012).
MLA (9th ed.) CitationMayr, Martina, et al. "Phase I Study of Imatinib, Cisplatin and 5-fluoruracil or Capecitabine in Advanced Esophageal and Gastric Adenocarcinoma." BMC Cancer, vol. 12, 2012.
Warning: These citations may not always be 100% accurate.